Letter to the editor: Several issues to consider in the study of hepatocellular carcinoma progression mechanism
Fan Yang, Shi‐Tao Jiang, Xin Lu, Yiyao Xu, Yong‐Chang Zheng – 10 July 2022
NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
Xiaowei Guo, Siyu Tan, Tixiao Wang, Renhui Sun, Shuangjie Li, Panpan Tian, Mengzhen Li, Yuzhen Wang, Yankun Zhang, Yuchuan Yan, Zhaoru Dong, Lunjie Yan, Xuetian Yue, Zhuanchang Wu, Chunyang Li, Kazuya Yamagata, Lifen Gao, Chunhong Ma, Tao Li, Xiaohong Liang – 10 July 2022
Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden
Satender Pal Singh, Nitisha Mondia – 9 July 2022
Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma
Dongyao Wang, Huiwen Wu, Jianxin Yang, Min Li, Changquan Ling, Zelong Gao, Hongtao Lu, Hui Shen, Yuxiao Tang – 9 July 2022 – It is interesting that high iron is an independent inducer or cofactor of hepatocellular carcinoma (HCC) while the amount of iron is decreased in the liver tumor tissues. Due to the previous findings that iron deficiency promoted HCC metastasis, it is of significance to identify the underlying mechanism of iron deficiency in HCC. The tumor iron content and expressions of iron‐metabolic molecules were observed in the primary liver cancers of rats and mice.
Sociodemographic and georaphic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis
Therese Bittermann, James D. Lewis, Cynthia Levy, David S. Goldberg – 9 July 2022
Reply
Hong Zhu, Bo Yang – 9 July 2022
The limited function of most circRNAs as a microRNA sponge
Ye‐Zhao Wang – 9 July 2022
Reply to: The limited function of most circRNAs as a microRNA sponge
Hui Li, Chang Liu, Hong Wu – 9 July 2022